A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
This study will examine the potential efficacy and safety of riluzole for core and associated
symptom domains of autism and will explore biological markers of safety and treatment
response.
Phase:
Phase 2
Details
Lead Sponsor:
Evdokia Anagnostou
Collaborators:
Holland Bloorview Kids Rehabilitation Hospital McMaster University St. Michael's Hospital, Toronto The Hospital for Sick Children Unity Health Toronto University of Toronto University of Western Ontario, Canada